← All companies

LNAI

Lunai Bioworks Inc.

LNAI Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.39

+0.45 +23.20%

Key statistics

from XBRL data in SEC filings

Market cap

$86.7M

Revenue (TTM)

$42.8K

Net income (TTM)

-$128M

EPS (TTM)

$2.08

P/E ratio

1.1

Dividend yield

—

Free cash flow

-$7.95M

Cash

$3.16M

Total assets

$9.86M

Gross margin

87.7%

52-week range

$1.21 – $21.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jun 17, 2026 8-K Other events Jun 16, 2026 8-K Other events May 20, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Shareholder vote results May 13, 2026 8-K/A Delisting notice or listing-rule failure May 11, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Delisting notice or listing-rule failure; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws May 1, 2026 8-K Other events Apr 28, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 30, 2026 8-K Other events Mar 5, 2026 8-K Delisting notice or listing-rule failure Feb 23, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Feb 12, 2026 8-K Entered a material agreement Dec 3, 2025 8-K Unregistered sale of equity Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Delisting notice or listing-rule failure Nov 6, 2025 8-K Shareholder vote results Nov 3, 2025 8-K Delisting notice or listing-rule failure Oct 30, 2025 8-K Delisting notice or listing-rule failure Oct 16, 2025 10-K Fiscal year ended 2025-06-30 Sep 29, 2025 8-K Modified rights of security holders; Amended charter or bylaws Sep 24, 2025 8-K Material impairment; Other events Sep 5, 2025 8-K Amended charter or bylaws Aug 26, 2025 8-K Delisting notice or listing-rule failure Aug 6, 2025 8-K Director or officer change Jul 25, 2025 8-K Delisting notice or listing-rule failure Jul 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 9, 2025 8-K Director or officer change Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Delisting notice or listing-rule failure Apr 18, 2025 8-K Unregistered sale of equity; Other events Apr 10, 2025 8-K Entered a material agreement Mar 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 28, 2025 10-Q Quarter ended 2024-12-31 Feb 19, 2025 10-Q/A Quarter ended 2024-09-30 Feb 19, 2025 10-K/A Fiscal year ended 2024-06-30 Feb 19, 2025 10-Q/A Quarter ended 2024-03-31 Feb 19, 2025 8-K Previously issued financials not reliable Feb 19, 2025 8-K Director or officer change Feb 10, 2025